Secondary humoral immunodeficiency

Drug	Drug Name	Drug Description
DB00028	Human immunoglobulin G	A purified form of human immunoglobulin G and other proteins used to treat immunodeficiency and a wide variety of autoimmune disorders.
DB06205	Hyaluronidase (human recombinant)	An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents.

Drug	Drug Name	Target	Type
DB00028	Human immunoglobulin G	Low affinity immunoglobulin gamma Fc region receptor III-B	target
DB00028	Human immunoglobulin G	Low affinity immunoglobulin gamma Fc region receptor III-A	target
DB00028	Human immunoglobulin G	High affinity immunoglobulin gamma Fc receptor I	target
DB00028	Human immunoglobulin G	Low affinity immunoglobulin gamma Fc region receptor II-a	target
DB00028	Human immunoglobulin G	Low affinity immunoglobulin gamma Fc region receptor II-b	target
DB00028	Human immunoglobulin G	Low affinity immunoglobulin gamma Fc region receptor II-c	target
DB00028	Human immunoglobulin G	High affinity immunoglobulin gamma Fc receptor IB	target
DB00028	Human immunoglobulin G	Complement C3	target
DB00028	Human immunoglobulin G	Complement C4-A	target
DB00028	Human immunoglobulin G	Complement C4-B	target
DB00028	Human immunoglobulin G	Complement C5	target
DB06205	Hyaluronidase (human recombinant)	Hyaluronic acid	target
DB06205	Hyaluronidase (human recombinant)	Transforming growth factor beta-1	target

Drug	Drug Name	Phase	Status	Count